Patents for A61L 31 - Materials for other surgical articles (30,010)
11/2002
11/07/2002WO2002087586A1 Sustained release drug delivery system containing codrugs
11/07/2002WO2002087481A1 Prevention of myocardial infarction induced ventricular expansion and remodeling
11/07/2002WO2002058775A3 Device for dilating and irradiating a vascular segment or body passageway
11/07/2002US20020165608 Local drug delivery devices and methods for maintaining the drug coatings thereon
11/07/2002US20020165607 Stent device and method
11/07/2002US20020165578 Surgical instrument
11/07/2002US20020165557 Retrieval device made of precursor alloy cable
11/07/2002US20020165337 Rapid-gelling biocompatible polymer composition and associated methods of preparation and use
11/07/2002US20020165265 Microtubule disrupter such as paclitaxel, and a polymeric carrier that is NOT a capsule; embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions
11/07/2002US20020164377 Mixture of retinoic acid and paclitaxel; polymeric carrier
11/07/2002US20020164365 Multifaceted compositions for post-surgical adhesion prevention
11/07/2002US20020162605 Suitable for use in magnetic resonance imaging (MRI)
11/07/2002DE10122128A1 Resorbierbares Patch-Implantat, Verfahren zu seiner Herstellung und Verwendung Absorbable patch implant, process for its preparation and use
11/07/2002DE10121623A1 Gewebe zum chirurgischen Verschluß von Hernien Tissue for surgical closure of hernias
11/07/2002CA2821193A1 Prevention of myocardial infarction induced ventricular expansion and remodeling
11/07/2002CA2747159A1 Biodegradable elastomer and method of preparing same
11/07/2002CA2446761A1 Medical device
11/07/2002CA2445357A1 Pyrazole derived kinase inhibitors
11/07/2002CA2445281A1 Prevention of myocardial infarction induced ventricular expansion and remodeling
11/07/2002CA2444241A1 Method and system for delivery of coated implants with an adhesion-resistant coating
11/06/2002EP1254916A2 Polysiloxane-containing polyurethane elastomeric compositions
11/06/2002EP1254674A1 Endovascular stent with coating comprising tacrolimus
11/06/2002EP1254673A1 Immuno-tolerant stent with surface microstructure
11/06/2002EP1254671A1 Collagen devices for regenerating nerves
11/06/2002EP1253953A1 Non-thrombogenic implantable devices
11/06/2002EP1253937A2 Methods of therapy with thrombin derived peptides
11/06/2002EP1253857A1 Device for the closure of a surgical puncture
11/06/2002EP1077654A4 Intra vascular implant and method of manufacture thereof
11/06/2002EP1071362A4 Anticoagulant internally coated needle
11/05/2002US6476070 Compositions useful for remodeling body spaces
11/05/2002US6476069 Compositions for creating embolic agents and uses thereof
11/05/2002US6475644 Medical devices for delivery of targeted radioisotopes
11/05/2002US6475502 Kits containing cyanoacrylate compositions comprising an antimicrobial agent
11/05/2002US6475434 Composition and methods for preventing and removing biofilm embedded microorganisms from the surface of medical devices
11/05/2002US6475234 Balloon expandable covered stents
11/05/2002US6475232 Stent with reduced thrombogenicity
11/05/2002US6475213 Method of ablating body tissue
11/05/2002US6475196 Subcutaneous infusion cannula
11/05/2002US6475182 Fluidic media introduction apparatus
10/2002
10/31/2002WO2002085425A1 Enhanced chronic lead removal
10/31/2002WO2002085424A1 A coating for a stent and a method of forming the same
10/31/2002WO2002085422A1 Drug delivery matrices to enhance wound healing
10/31/2002WO2002085387A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
10/31/2002WO2002085386A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002WO2002085385A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
10/31/2002WO2002085384A2 Lubricious coatings for substrates
10/31/2002WO2002085299A2 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002WO2002085255A1 Improved surgical stent and method for preventing occlusion of stented vessels and conduits after implantation of stents
10/31/2002WO2002085253A1 Drug delivery platform and methods for the inhibition of neointima formation
10/31/2002WO2002058750A3 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same
10/31/2002WO2002047582A3 Expandable stent with sliding and locking radial elements
10/31/2002US20020161450 Instrument for regenerating living organism tissue or organ
10/31/2002US20020161399 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers
10/31/2002US20020161376 Method and system for delivery of coated implants
10/31/2002US20020161371 Fixative device
10/31/2002US20020161170 Photopolymerization; medical equipment
10/31/2002US20020161168 Amorphous polymeric polyaxial initiators and compliant crystalline copolymers therefrom
10/31/2002US20020161114 Shape memory polyurethane or polyurethane-urea polymers
10/31/2002US20020161065 Incubating photo-initiator-coated polymeric material with an aqueous monomer capable of free radical polymerization and exposing incubating polymeric material to UV light creating a modified surface; medical implants, stents
10/31/2002US20020160508 Fibrin polymer structure
10/31/2002US20020160098 Nucleic acid coating compositions and methods
10/31/2002US20020160036 Covering area of mucosa injury with mucosa-regenerating preparation comprising a membrane comprised of a purified collagen material derived from natural collagen-containing tissue, fixing membrane, allowing area to regenerate mucosa
10/31/2002US20020160033 Non-woven framework containing pores having an average size of at least 40 mu m and metal or polymer fibers; stents
10/31/2002CA2681952A1 Drug delivery matrices to enhance wound healing
10/31/2002CA2445740A1 Use of metals to treat inflammatory skin conditions
10/31/2002CA2445734A1 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002CA2445729A1 Use of metals to treat mucosal membranes
10/31/2002CA2445389A1 Antimicrobial polymeric surfaces
10/31/2002CA2444032A1 Enhanced chronic lead removal
10/31/2002CA2443587A1 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/30/2002EP1252905A2 Resorbable patch implant, process for producing same and its use
10/30/2002EP1252903A1 Collagen containing membranes for use in mucosa regeneration
10/30/2002EP1252516A1 Method of treating a surface of an object with a hydrophobin-containing solution
10/30/2002EP1252193A1 Water insoluble derivatives of polyanionic polysaccharides
10/30/2002EP1251973A1 Plasma-deposited coatings, devices and methods
10/30/2002EP1251902A1 Medical device
10/30/2002EP1251901A1 Medical devices that resist restenosis
10/30/2002EP1251890A2 Transmural concentric multilayer ingrowth matrix within well-defined porosity
10/30/2002EP1251889A1 Proteinaceous coating
10/30/2002EP1251799A1 Braided branching stent, method for treating a lumen therewith, and process for manufacture thereof
10/30/2002EP1203038A4 Shape memory polyurethane or polyurethane-urea polymers
10/30/2002EP1140242B1 Polymer compositions for intraluminal stent
10/30/2002EP0901352B1 Endoluminal prostheses having position indicating markers
10/30/2002CN1377246A Cutting blade for a surgical instrument
10/30/2002CN1376735A Antibiotics-polymer composition
10/30/2002CN1376469A Slow release antibiotics preparation of bioactive substance
10/29/2002US6472502 Absorbable copolylactides and their use
10/29/2002US6471987 Ligating band comprises an elastomeric layer and an inner drug releasing layer; chemotherapeutic agent for treating a mucosa, polyp or other growth
10/29/2002US6471980 Luminal prostheses which allow for programmed and controlled mycophenolic acid delivery with increased efficacy to selected locations within a patient's vasculature to inhibit restenosis and hyperplasia
10/29/2002US6471979 Applying formulation comprising a sex hormone, anti-hormone, sex-hormone agonist, steroid-hormone inhibitor/antagonist (partial or full), selective estrogen receptor modulator (serm) to stent; inserting stent for releasing formulation
10/29/2002US6471699 Systems and methods for forming elongated lesion patterns in body tissue using straight or curvilinear electrode elements
10/29/2002US6471687 Implantable containment apparatus for a therapeutical device
10/27/2002CA2383636A1 Collagen membrane for mucosa regeneration
10/24/2002WO2002083215A1 Intradermal needle
10/24/2002WO2002083176A2 Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming
10/24/2002WO2002082907A1 Novel antiseptic derivatives with broad spectrum antimicrobial activity for the impregnation of surfaces
10/24/2002WO2002067788B1 Immobilizing objects in the body
10/24/2002WO2002046760A3 Method of immobilising molecules and particles on a hydrophobic polymer surface wherein mucin is used
10/24/2002WO2002032397A9 Electroprocessing in drug delivery and cell encapsulation
10/24/2002WO2001068135A9 Compositions and methods for affecting osteogenesis